SCHEMBL6132449

SCHEMBL6132449

COc1ccc(CC2NC(=O)CNC2=O)cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.46
TACR1 P25103 1/20 0.40
CXCR4 P61073 3/20 0.39
MAPT P10636 3/20 0.39
KDM4E B2RXH2 2/20 0.39
PDE4A P27815 2/20 0.39
MAPK1 P28482 2/20 0.39
PDE4B Q07343 2/20 0.39
PDE4D Q08499 2/20 0.39
ALDH1A1 P00352 2/20 0.39
GLA P06280 1/20 0.39
HTT P42858 1/20 0.39
TNF P01375 1/20 0.39
LMNA P02545 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39
MEN1 O00255 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6133060 0.90 HRH3 (0.46) HRH3TACR1CXCR4MAPTKDM4E
SCHEMBL5371933 0.81 HRH3 (0.43) HRH3TACR1CXCR4MAPTKDM4E
SCHEMBL17451 0.78 HRH3 (0.46) HRH3CXCR4ALDH1A1
SCHEMBL12809721 0.78 HRH3 (0.53) HRH3CXCR4ALDH1A1SMN1; SMN2
SCHEMBL18293 0.77 HRH3 (0.46) HRH3CXCR4
SCHEMBL5368655 0.76 HRH3 (0.46) HRH3TACR1CXCR4MAPTKDM4E
SCHEMBL6132966 0.74 OPRK1 (0.43) HRH3KDM4EALDH1A1LMNAMEN1
SCHEMBL12809436 0.72 HRH3 (0.53) HRH3CXCR4
SCHEMBL3205012 0.72 HRH3 (0.53) HRH3CXCR4
SCHEMBL21683131 0.72 HRH3 (0.53) HRH3CXCR4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6924278-B2 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-08-02 US disclosed
US-20050027121-A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-02-03 US disclosed
US-20030114668-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-06-19 US disclosed
EP-0993457-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-19 EP disclosed
WO-1998057954-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050027121-A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists TAC3, TACR1, SSTR5 HRH3 229/4885TACR1 2/4885CXCR4 1737/4885
US-20030114668-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS TACR1, NPSR1, SSTR2 HRH3 31/4885TACR1 1/4885CXCR4 1235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.